Clinical bottom line
Exercise-based cardiac rehabilitation (CR) following myocardial infarction (MI) is associated with significant long-term reductions in mortality and recurrent cardiovascular events. CR also improves functional capacity, quality of life, and cognitive outcomes, with benefits observed across age and sex subgroups. Despite robust evidence supporting CR, adherence remains suboptimal, and tailored strategies are needed to enhance participation and sustain long-term benefits.
What the evidence shows
Lawler et al. (2011) conducted a comprehensive systematic review and meta-analysis of randomized controlled trials demonstrating that exercise-based CR post-MI reduces all-cause mortality by approximately 20% and lowers the risk of recurrent MI. These benefits are attributed to improved cardiovascular fitness, risk factor modification, and psychosocial support.
Popiolek-Kalisz et al. (2026) highlight that both sex and age influence response to early post-MI CR, with older adults and women deriving comparable functional and clinical benefits, although barriers to participation may differ. This underscores the importance of inclusive referral and individualized program design.
Ramachandran et al. (2026) explored patient motivation, barriers, and satisfaction related to CR adherence, finding that personalized support and addressing logistical challenges are key to improving long-term engagement and outcomes.
Beyond cardiovascular endpoints, Zergaw et al. (2024) systematically reviewed the impact of CR on cognitive function in older post-MI patients, reporting improvements in executive function and memory, which may contribute to enhanced overall recovery and independence.
Kim et al. (2015) compared long-term outcomes of CR in diabetic versus non-diabetic MI patients, observing that both groups benefit from CR, though diabetic patients may require more intensive risk factor management.
Caveats and uncertainty
Most evidence derives from exercise-based CR programs in high-resource settings, potentially limiting generalizability to low-resource or rural environments.
Variability in CR program components, duration, and intensity complicates standardization and comparison across studies.
Adherence remains a critical challenge, with many patients failing to complete recommended CR, attenuating potential benefits.
Data on the incremental benefit of CR combined with optimized pharmacotherapy, such as statins, require further exploration (Pahlajani et al., 2016; Aronow et al., 2014).
Long-term cognitive benefits need confirmation in larger, prospective trials.
How this may change practice
Clinicians should prioritize referral to exercise-based CR for all eligible post-MI patients, including older adults and women, with attention to overcoming barriers to participation.
Tailored interventions addressing patient motivation, socioeconomic factors, and logistical challenges can improve adherence and outcomes.
Integration of cognitive assessments and support into CR programs may enhance holistic recovery.
Ongoing coordination with pharmacological management is essential to maximize secondary prevention.
Health systems should expand access to CR, including home-based and telehealth options, to reach underserved populations.